Cargando…
SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia
BACKGROUND: Aberrant DNA methylation plays a crucial role in the progression of myeloid neoplasms. Previously, our literature reported that slit guidance ligand 2 (SLIT2) promoter methylation was associated with disease progression and indicated a poor prognosis in patients with myelodysplastic synd...
Autores principales: | Wu, De-long, Wang, Yun, Zhang, Ting-juan, Chu, Ming-qiang, Xu, Zi-jun, Yuan, Qian, Ma, Ji-chun, Lin, Jiang, Qian, Jun, Zhou, Jing-dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677675/ https://www.ncbi.nlm.nih.gov/pubmed/36411451 http://dx.doi.org/10.1186/s40001-022-00899-2 |
Ejemplares similares
-
Hypermethylation of secreted frizzled-related proteins predicts poor prognosis in non-M3 acute myeloid leukemia
por: Guo, Hong, et al.
Publicado: (2017) -
SOX30 methylation correlates with disease progression in patients with chronic myeloid leukemia
por: Zhang, Ting-Juan, et al.
Publicado: (2019) -
Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression
por: Narayan, Gopeshwar, et al.
Publicado: (2006) -
BCL7A is silenced by hypermethylation to promote acute myeloid leukemia
por: Patiño-Mercau, Juan Rodrigo, et al.
Publicado: (2023) -
The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML)
por: Yan-Fang, Tao, et al.
Publicado: (2013)